Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers

NCT03400332

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • Local Institution - 0059 Springdale, Arkansas, United States
  • Local Institution - 0099 Los Angeles, California, United States
  • Local Institution - 0007 Lakewood, Colorado, United States
  • Local Institution - 0087 Atlanta, Georgia, United States
View all 72 locations
View Trial Details
Completed

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)

NCT03820986

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations
  • The Angeles Clinic and Research Institute ( Site 0707) Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0704) San Francisco, California, United States
  • California Pacific Medical Center Research Institute ( Site 0705) San Francisco, California, United States
  • John Wayne Cancer Institute ( Site 0706) Santa Monica, California, United States
View all 119 locations
View Trial Details
Completed

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

NCT02910557

Conditions
Herpetic Infection, Melanoma, Neoplasms, +10 more
Locations
  • Corazon United States of America, LLC doing business as Life Clinical Trials Coral Springs, Florida, United States
  • Mercy Medical Center Baltimore, Maryland, United States
  • Jefferson City Medical Group PC Jefferson City, Missouri, United States
  • TriHealth Cancer Institute - Kenwood Cincinnati, Ohio, United States
View all 23 locations
View Trial Details
Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

NCT02989064

Conditions
Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Completed

A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma

NCT05419388

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia
  • Melanoma Institute Australia North Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
View all 22 locations
View Trial Details

Related conditions